We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 22,923

Social Media and Litigation Risks
  • Russell Kennedy
  • Australia
  • April 28 2017

The goal is to remain relevant, to convert passive responses into active engagement, and to drive brand recognition and loyalty. You remain


FDA Commissioner Nominee Gottlieb Written Responses Signal Support for Food Safety and Science-Based Approach to Consumer Communications
  • Kelley Drye & Warren LLP
  • USA
  • April 27 2017

Dr. Scott Gottlieb, recently submitted written responses to questions posed by members of the Senate Health, Education, Labor and Pensions Committee


The US and the EU agree to mutually recognize their medicine inspections
  • CMS, Belgium
  • European Union, USA
  • April 27 2017

The United States and the European Union have agreed to recognize each other’s drug inspections. This mutual recognition is based on the legal


New regulation on medical devices
  • CMS, Belgium
  • European Union
  • April 27 2017

On 5 April 2017, the Regulation on medical devices and the Regulation on in vitro diagnostic medical devices were formally adopted. These Regulations


Navigating the "Made in America" Landscape
  • Venable LLP
  • USA
  • April 27 2017

With the signing of a new so-called Buy American, Hire American Executive Order, President Trump is trying to make good on his campaign promise to


Dish Soap, Potato Chips, Coffee Drinks: Slack Fill Lawsuits Fill up the Courts
  • Manatt Phelps & Phillips LLP
  • USA
  • April 27 2017

They may be based on empty air, but slack fill lawsuits are filling up the courts, with new cases challenging everything from dish soap to potato


Geneesmiddelen voor geavanceerde therapie in het kader van de “ziekenhuisuitzondering”
  • CMS, Belgium
  • Belgium
  • April 27 2017

Op 1 maart 2017 werd een nieuw koninklijk Besluit met betrekking tot geneesmiddelen voor geavanceerde therapie in het Belgisch Staatsblad


NAD Recommends Nautilus Discontinue “All You Have to Do Is Walk” Claims with Its Bowflex TreadClimber
  • Winston & Strawn LLP
  • USA
  • April 27 2017

The NAD recently recommended that Nautilus Inc. discontinue the express claims in connection to its TreadClimber fitness machine, including the


Off-label use of medicinal products in the EU (facts and figures published in an EU study report)
  • CMS DeBacker
  • European Union
  • April 27 2017

Off-label use of a medicinal product is the prescription of it without following the information provided on the leaflet or the summary of product


Ninth Circuit Reaffirms No Private Cause of Action for “Lack of Substantiation” Under California’s Unfair Competition and Consumer Protection Laws
  • Sidley Austin LLP
  • USA
  • April 26 2017

On April 21, 2017, the Ninth Circuit held that a district court in the Northern District of California “correctly